A detailed case study by Dr. Marisa Kassimir, ND, showcasing how homeopathy, nutritional therapy, and lifestyle interventions ...

Chronic workplace stress doesn’t just stay bottled up in your headspace. Instead, it manifests physically, particularly ...

Researchers have found in a new study that a significant association between psoriasis severity and apical periodontitis (AP) ...

Not everyone who has psoriasis will get psoriatic arthritis, even though the conditions are often related. Psoriasis causes patches of scaly, red, or white skin called plaques. Psoriatic arthritis ...

Along with your symptoms, the most telling signs are the skin and nail changes you get with psoriasis, or specific changes in your X-rays. You may get referred to a rheumatologist-- doctors who ...

The following is a summary of “Treatment of plaque psoriasis with guselkumab reduces systemic inflammatory burden as measured by neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and ...

When you have psoriasis, you may also have concerns about passing the condition on to your child. Psoriasis doesn't cause female infertility and shouldn't affect your chances of getting pregnant.

The cost of biologic medications used to treat plaque psoriasis has increased over time, according to a new study published in JAMA Dermatology. However, researchers found that costs could be ...

Icotrokinra appears to be an effective treatment for adolescent patients with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study. The randomized, ...

Additionally, some infections may exacerbate or trigger psoriasis, such as strep throat. Regardless of whether you are on a biologic or immunosuppressive medication for psoriasis, it’s essential ...

Please provide your email address to receive an email when new articles are posted on . Overall, 84.1% and 70.5% of patients treated with icotrokinra achieved IGA 0 or 1 and PASI 90, respectively ...

Deucravacitinib use for 4 years among patients with plaque psoriasis was associated with maintained improvements in several clinical- and patient-reported outcomes, as well no new safety signals.